Latest Early-onset Alzheimer's disease Stories
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
Researchers using two brain-imaging technologies have found that apparently normal older individuals with brain deposits of amyloid beta â€“ the primary constituent of the plaques found in the brains of Alzheimer's disease patients â€“ also had changes in brain structure similar to those seen in Alzheimer's patients.
Growing evidence shows that if one of your parents has Alzheimerâ€™s disease, the chances of inheriting it from your mother are higher than from your father, according to this study.
Results from a new study contribute to growing evidence that if one of your parents has Alzheimer's disease, the chances of inheriting it from your mother are higher than from your father.
Like two brothers wrestling fighting who need to be put in separate corners, a pair of protein molecules work together to speed up the toxic events of Alzheimerâ€™s disease.
A new study from the Centre for Addiction and Mental Health (CAMH) has found evidence suggesting that a variation of a specific gene may play a role in late-onset Alzheimer's, the disease which accounts for over 90% of Alzheimer's cases.
Like two unruly boys who need to be split up in class, a pair of protein molecules work together to speed up the toxic events of Alzheimer's disease.
A Global Consortium Aims to Discover and Map all the Alzheimer's Genes CHICAGO, Feb.
23andMe has released its first annual list of what it felt to be the 10 most interesting and significant genetic findings in 2010, as part of an ongoing journey to understand the role of genetics in personal health and human development.
Researchers at the University of British Columbia and Vancouver Coastal Health Research Institute have discovered that the genetic mechanism which destroys brain cells is responsible for early development of Alzheimer's Disease in people with Down Syndrome and for development of Alzheimer's Disease in general population â€“ providing a potential new target for drugs that could forestall dementia in people with either condition.